Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

LFSCvsXHEETF Comparison

ETF 1
LFSC

F/m Emerald Life Sciences Innovation ETF

This fund is part of
Life Sciences
-0.51%
VS
ETF 2
XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
+0.15%

F/m Emerald Life Sciences Innovation ETF (LFSC) belongs to the Life Sciences segment. State Street SPDR S&P Health Care Equipment ETF (XHE) is part of the US Health Care segment. LFSC's top 3 sector exposures are Healthcare and Sovereign. In contrast, XHE's top sector exposures are Healthcare and Finance. LFSC is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.35% for XHE. LFSC is up 23.23% year-to-date (YTD) with +$8M in YTD flows. XHE performs worse with -3.33% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of LFSC and XHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

LFSC vs XHE performance and flow charts

Performance

024681012%Jun 22Jun 29Jul 6Jul 13Jul 20

Cumulative Flows

0 M1 M2 M3 M4 M5 M6 MJun 22Jun 29Jul 6Jul 13Jul 20

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
LFSC
XHE
+4.17%+5.83%
+20.39%+2.12%
+23.23%-3.33%
+82.30%+9.18%
n/a-12.44%
n/a-32.06%
Flows
LFSC
XHE
+$2M+$6M
+$3M+$4M
+$8M+$4M
+$17M-$15M
--$377M
--$395M
Volatility and drawdown
3M1Y3Y5Y
Volatility
LFSC
XHE
+26.23%+26.32%
+26.91%+22.80%
n/a+22.21%
n/a+24.71%
Max drawdown
LFSC
XHE
-6.53%-7.15%
-16.25%-18.20%
n/a-32.21%
n/a-49.90%
Max drawdown duration
LFSC
XHE
20d63d
168d195d
n/a1092d
n/a1784d
Trading data

Create an account to view trading data

Join for free
LFSC
XHE
Last sale
7/24/2026 at 1:30 PM
$45.10
$85.18
Previous close
07/23/2026
$45.46
$85.02
Consolidated volume
07/23/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

LFSC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
LFSC
XHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
LFSC
XHE
Last price
$45.10
$85.18
1D performance
-0.79%
+0.19%
AuM$123.48 M$153.34 M
E/R0.79%0.35%
Characteristics
LFSC
XHE
Management strategyActivePassive
ProviderEmerald GroupState Street Investment Management
Benchmark-S&P Health Care Equipment Select Industry Index
N° of holdings4067
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateOctober 31, 2024January 26, 2011
ESGNoNo
Advertisement
Exposure

Countries

LFSC
USA
90.9%
United Kingdom
7.04%
Other
2.06%
XHE
USA
89.54%
Other
10.46%

Sectors

LFSC
Healthcare
98.03%
Other
1.97%
XHE
Healthcare
94.54%
Other
5.46%
Advertisement

Diversification

LFSC

Total weight of top 15 holdings out of 15

73.24%
XHE

Total weight of top 15 holdings out of 15

26.73%

Top 15 holdings

Data as of June 30, 2026
LFSC
Travere Therapeutics, Inc.
8.37%
Cogent Biosciences, Inc.
7.18%
LivaNova Plc
7.04%
Spyre Therapeutics, Inc.
6.71%
Guardant Health, Inc.
5.56%
Corcept Therapeutics, Inc.
5.27%
Mirum Pharmaceuticals, Inc.
5.25%
BillionToOne, Inc.
4.25%
Cytokinetics, Inc.
4.13%
Veradermics, Inc.
3.76%
United Therapeutics Corp.
3.55%
Trevi Therapeutics, Inc.
3.50%
Savara, Inc.
3.20%
Dianthus Therapeutics, Inc.
2.77%
Nektar Therapeutics
2.70%
XHE
Butterfly Network, Inc.
2.45%
QuidelOrtho Corp.
2.04%
Glaukos Corp.
1.79%
UFP Technologies, Inc.
1.79%
Axogen, Inc.
1.76%
Lantheus Holdings, Inc.
1.74%
Artivion, Inc.
1.73%
Envista Holdings Corp.
1.72%
Omnicell, Inc.
1.71%
Medline, Inc.
1.69%
Alphatec Holdings, Inc.
1.67%
Dentsply Sirona, Inc.
1.66%
Inspire Medical Systems, Inc.
1.66%
The Cooper Cos., Inc.
1.66%
Edwards Lifesciences Corp.
1.65%
Frequently asked questions about LFSC and XHE

How have the LFSC and XHE ETFs performed in 2026?

As of July 24, 2026, LFSC is up 23.23% year-to-date (YTD), while XHE has lost -3.33%. That puts LFSC better performer ahead so far this year.

Which ETF is attracting more investor money: LFSC or XHE?

Year-to-date, the LFSC ETF saw +$8M in flows, compared to +$4M for XHE.

Which ETF is more volatile: LFSC or XHE?

Over the past year, LFSC had a volatility of 26.91%, while XHE experienced 22.8%.

Which ETF is bigger: LFSC or XHE?

As of July 24, 2026, LFSC holds $123.48 M in assets under management (AUM), while XHE manages $153.34 M.

What sectors do the LFSC and XHE ETFs invest in?

LFSC leans toward sectors like Healthcare. Meanwhile, XHE focuses on Healthcare.

What are the top holdings of the LFSC ETF and XHE ETF?

LFSC top holdings include Travere Therapeutics, Inc., Cogent Biosciences, Inc. and LivaNova Plc. XHE holds in its top three: Butterfly Network, Inc., QuidelOrtho Corp. and Glaukos Corp..

Which ETF is more diversified: LFSC or XHE?

LFSC holds 40 securities with 73.24% of its assets in the top 15. XHE has 67 securities and a top 15 weight of 26.73%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up